(Q34170794)

31 July 2017

title

Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis (English)

1 reference

31 July 2017

1 reference

Liangwei Li

1

1 reference

31 July 2017

Yinwei Zhang

2

1 reference

31 July 2017

Jingjuan Qiao

3

1 reference

31 July 2017

Jenny J Yang

4

1 reference

31 July 2017

Zhi-Ren Liu

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 July 2014

1 reference

Journal of Biological Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

289

1 reference

31 July 2017

issue

37

1 reference

31 July 2017

page(s)

25812-25821

1 reference

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Evidence for an alternative glycolytic pathway in rapidly proliferating cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase M2 is a phosphotyrosine-binding protein

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

M2-PK as a novel marker in ovarian cancer. A prospective cohort study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Tumor markers in detection of lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Metabolic profiling of cell growth and death in cancer: applications in drug discovery

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162182

Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1074%2FJBC.M114.576934

Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1074%2FJBC.M114.576934

Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1074%2FJBC.M114.576934

Quantitative detection of tumor M2-PK in serum and plasma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25070887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25070887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25070887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1074/JBC.M114.576934

1 reference

31 July 2017

1 reference

31 July 2017

1 reference